Psychosocial and quality of life assessment in cancer patients: a pilot study in Indian set up

Santanu Chaudhuri, Sanjeev K. Gupta, Debashis Panda, Navin Kumar, Neeraj Kumar, Vani Ganpathi, Pushpanjali Vishwakarma, Mamta Sharma


Background: Routine screening for distress is internationally recommended as a standard of care among cancer patients. This study was conducted to assess the level of stress and determine the association between quality of life (QOL) with demographic, socio-economic status, treatment phase, cancer stage, etc.

Methods: An observational study, performed in the department of Clinical Oncology, Nayati Multi Super Speciality Hospital, Mathura, India. Data of 62 histopathologically proven cancer patients between Nov 2016 and July 2018, were analyzed. This pilot study was conducted to assess the QOL and stress levels of cancer patients by using scales of WHOQOL-BREF, QSC-R23 and Hamilton scale.

Results: Among 62 cancer patients, high distress along with poor QOL was seen maximum in males, 40-60 year age group and educated. In majority of domains, high distress was found in middle class, whereas poor QOL was found in Lower class in Environmental domain (p<0.01). We found higher distress in nuclear families (p<0.05). High distress was seen in cancer patients who were aware of illness and was found to statistically significant. Poor QOL in stage 4 was found to be statistically significant in Psychological domain of WHOQOL-BREF. High distress was found in patients undergoing treatment in all patients as compared to Pre-treatment phase and Post-treatment phase (p<0.05).

Conclusion: To assess psychological stress in cancer patients using all three scales we could not obtain a conclusive result covering all dimensions of QOL. So, in our next study authors plan to develop one indigenous new scale.


Cancer patients, Psychosocial assessment, Psychological distress, Quality of life

Full Text:



Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Tomi F, et al. Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study. JAMA oncol. 2017;3(4):524-48.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):359-86.

Andersen BL, DeRubeis RJ, Berman BS, Gruman J, Champion VL, Massie MJ, et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014;32(15):1605-19.

Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, et al. The prevalence of psychiatric disorders among cancer patients. JAMA. 1983;249(6):751-7.

Herschbach P, Book K, Brandl T, Keller M, Lindena G, Neuwöhner K, et al. Psychological distress in cancer patients assessed with an expert rating scale. Br J Cancer. 2008;99(1):37-43.

Krebber AM, Buffart LM, Klejin G, Reipma IC, Bree RD, Leemans CR et al. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology. 2014;23(2):121-30.

World Health Organization. Division of Mental Health and Prevention of Substance Abuse. WHOQOL: measuring quality of life. Geneva: World Health Organization. 1997

Moreno-Smith M, Lutgendorf SK, Sood AK. Impact of stress on cancer metastasis. Future Oncol. 2010;6(12):1863-81.

Lutgendorf SK, Sood AK, Anderson B, McGinn S, Maiseri H, Dao M, et al. Social support, psychological distress, and natural killer cell activity in ovarian cancer. J Clin Oncol. 2005;23(28):7105-13.

Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: A meta-analysis. Cancer. 2009;115(22):5349-61.

Steel JL, Geller DA, Gamblin TC, Olek MC, Carr BI. Depression, immunity, and survival in patients with hepatobiliary carcinoma. J Clin Oncol. 2007;25(17):2397-405.

Stommel M, Given BA, Given CW. Depression and functional status as predictors of death among cancer patients. Cancer. 2002;94(10):2719-27.

Yousaf U, Christensen ML, Engholm G, Storm HH. Suicides among Danish cancer patients 1971–1999. Br J Cancer. 2005;92(6):995-1000.

Grassi L, Johansen C, Annunziata MA, Capovilla E, Costantini A, Gritti P, et al. Screening for Distress in Cancer Patients: A Multicenter, Natonwide Study in Italy. Cancer. 2013;119(9):1714-21.

Mitchell AJ, Hussain N, Grainger L, Symonds P. Identification of patient-reported distress by clinical nurse specialists in routine oncology practice: a multicentre UK study. Psychooncol. 2011;20(10):1076-83.

Herschbach P, Marten-Mittag B, Henrich G. Revision und psychometrische Prüfung des fragebogens zur belastung von krebskranken (FBK–R23). Z Med Psychol. 2003;12(2):69-76.

Harper A, Power M. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28(3):551-8.

Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatr. 1960;23(1):56-62.

Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361-70.

Chaudhuri S, Gupta SK, Kumar N, Panda D, Kumar N, Radia A, et al. A comparative analysis of the effects of Non-smoked tobacco on oral mucosa over smoked and alcohol use in Northern Indian population. International journal of basic and applied research. 2018;8(2):30-41.

Chaudhuri S, Gupta SK, Kumar N, Panda D, Kumar N, Aneesh PM, et al. Can India Win the Fight In Narrowing The Gap Between Metro Centric Cancer Care And Rural Outreach?. Int J Cur Adv Res. 2018;07:15074-81.

Fleck MP, Louzada S, Xavier M, Chachamovitch E, Vieira G, Santos L, et al. Application of the Portuguese version of the instrument for the assessment of quality of life of the World Health Organization (WHOQOL-100). Rev Saúde Pública. 1999;33(2):198-205.

Goodwin PJ, Leszcz M, Ennis M, Koopmans J, Vincent L, Guther H, et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med. 2001;345(24):1719-26.

Coyne JC, Stefanek M, Palmer SC. Psychotherapy and survival in cancer: The conflict between hope and evidence. Psychol Bull. 2007;133(3):367-94.

Newell SA, Sanson-Fisher RW, Savolainen NJ. Systematic review of psychological therapies for cancer patients: Overview and recommendations for future research. J Natl Cancer Inst. 2002;94(8):558-84.

Mystakidou K, Tsilika E, Parpa E, Pathiaki M, Galanos A, Vlahos L, et al. The relationship between quality of life and levels of hopelessness and depression in palliative care. Depress Anxiety. 2008;25(9):730-36.

Götze H, Brähler E, Gansera L, Polze N, Köhler N. Psychological distress and quality of life of palliative cancer patients and their caring relatives during home care. Support Care Cancer. 2014;22(10):2775-82.

Abuelgasim KA, Ahmed GY, Malik MA. Depression and anxiety in patients with hematological malignancies, prevalence, and associated factors. Saudi Med J. 2016;37(8):877-81.

Nikbakhsh N, Moudi S, Abbasian S, Khafri S. Prevalence of depression and anxiety among cancer patients. Caspian J Int Med. 2014;5(3):167-70.

Hong JS, Tian J. Prevalence of anxiety and depression and their risk factors in Chinese cancer patients. Support Care Cancer. 2014;22(2):453-59.

Ell K, Sanchez K, Vourlekis B, Lee PJ, Dwight-Johnson M, Lagomasino I, et al. Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer. J Clin Oncol. 2005;23(13):3052-60.

Karunanithi G, Sagar RP, Joy A, Vedasoundaram P. Assessment of Psychological Distress and its Effect on Quality of Life and Social Functioning in Cancer Patients. Indian J Palliat Care. 2018;24(1):72-7.

Mhaidat NM, Alzoubi KH, Al-Sweedan S, Alhusein BA. Prevalence of depression among cancer patients in Jordan: a national survey. Support Care Cancer. 2009;17(11):1403-07.

Krebber AMH, Buffart LM, Klejin G, Reipma IC, Bree RD, Leemans CR, et al. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncol. 2014;23(2):121-30.

Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ. 2005;330(7493):702.

Mhaidat NM, Ai-Sweedan SA, Alzoubi KH, Alazzam SI, Banihani MN, Yasin MO, et al. Prevalence of depression among relatives of cancer patients in Jordan: a cross-sectional survey. Palliat Support Care. 2011;9(1):25-9.